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Nuclear factor kappa B (NF-KB) is a DNA-binding regulatory factor that controls the transcription of a number of genes. Various agents are known 
to activate this factor. We have studied the ability of CAMP to stimulate NF-nB activity in human myeloid cells. Electrophoretic mobility assay 
revealed that structural CAMP analogs and agents elevating intracellular CAMP levels induced NF-KB DNA-binding activity. The inducibility was 
dependent on the maturation stage of myeloid cells. In promyelocytic HL-60 cells CAMP induced higher NF-nB activity than in more differential 
THP-1 cells and in human monocytes. By transfecting HL-60 and THP-1 cells with reporter constructs containing NF-lcB DNA-binding sites, we 
observed that CAMP-induced NF-KB was transcriptionally active. 
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1. INTRODUCTION 
Transcription of eukaryotic genes is regulated by a 
number of nuclear factors that bind to specific DNA 
sequences. Some nuclear factors are present in all tis- 
sues as a part of the general transcription machinery. 
On the other hand, another group of transcription fac- 
tors are induced after specific stimuli in a tissue-specific 
manner. Nuclear factor kappa B (NF-lcB) is one of the 
transcription factors which is inducible by a variety of 
stimuli in different cell types [1,2]. NF-KB is typically 
described as a complex of two proteins with molecular 
sizes of 50 and 65 kDa. It has now been shown that the 
subunits of NF-KB share significant homology with the 
proto-oncogene c-rel[3-51. Both p.50 and ~65 can inter- 
act with related DNA sequences as a homo- or hetero- 
dimer, and in addition the product of proto-oncogene 
c-rel can bind to similar DNA motifs by itself or as a 
heterodimer with ~50 or ~65 [6-81. In unstimulated cells 
a cytoplasmic inhibitor protein (IKB) interacts with 
NF-KB, thereby inhibiting its activity [9]. After cellular 
activation NF-rcB is released from IKB and translocated 
to the nucleus, where it binds to the KB motif (5’-GG- 
GACTTTCC-3’) or related DNA sequences. Recently 
several IlcB molecules have been described [l&l 31. 
These molecules specifically interact with ~50, ~65 or 
rel-related proteins. 
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Abbreviations: CAT, chloramphenicol acetyltransferase (EC 2.3.1.28); 
BrcAMP, 8-bromoadenosine 3’:5’-cyclic monophosphate; Bt,cAMP, 
NJ’-U-dibutyryladenosine 3’:5’-cyclic monophosphate; EMSA, elec- 
trophoretic shift assay; IBMX, 3-isobutyl-1-methyl-xanthine; LPS, 
bacterial ipopolysaccharide; PKA, protein kinase A; PKC, protein 
kinase C. 
Various agents are known to activate NF-KB, includ- 
ing mitogens, cytokines, viruses and agents provoking 
oxidative stress [2]. In the present report, we have eval- 
uated the ability of CAMP to stimulate NF-KB activity 
in human myeloid cells. HL-60 cells are from the pro- 
myelocytic stage of differentiation and THP-1 cells re- 
semble human monocytes. Our findings show that in 
human promyelocytic HL-60 cells, the CAMP analogs 
and agents elevating intracellular CAMP levels induce 
a significant NF-XB activity, but that in more mature 
THP-1 cells and human monocytes NF-KB activity is 
poorly induced. 
2. MATERIALS AND METHODS 
2.1. Cell cultures 
Leucocyte-rich buffy coats were obtained from the Finnish Red 
Cross Blood Transfusion Service (Helsinki, Finland). Mononuclear 
cells were isolated from buffy coats by Ficoll-Isopaque centrifugation 
(Pharmacia, Uppsala, Sweden) and resuspended in RPMI-1640 me- 
dium (Flow Laboratories, Irvine, Scotland, UK) containing 10% 
human AB serum (Finnish Red Cross Blood Transfusion Service), 10 
mM HEPES, 2 mM L-glutamine and antibiotics. After 1 h of culture 
in Petri dishes (Nunc, Roskilde, Denmark) non-adherent cells were 
removed by vigorous pipetting with warm RPMI-1640 medium con- 
taining 20 mM HEPES. To avoid inter-individual variations between 
the buffy coats, each experimental group consisted of cells from 5 
buffy coats. 
The HL-60 and THP-1 cell lines were obtained from the American 
Type Culture Collection (Rockville, MD, USA). The cells were cul- 
tured in RPM1 1640 medium containing 10 mM HEPES, 2 mM 
L-glutamine, antibiotics and 10% fetal calf serum (Gibco Life Tech- 
nologies Ltd., Paisley, Scotland, UK). THP-1 medium also contained 
70 PM 2-mercaptoethanol. The cell cultures were stimulated with 
NJ-O-dibutyryladenosine 3’:S’cyclic monophosphate (Bt,cAMP), 
8-bromoadenosine 3’:5’-cyclic monophosphate (BrcAMP), forskolin 
or 3-isobutyl-1-methyl-xanthine (IBMX), which were all from Sigma 
Chemical Co. (St. Louis, MO, USA) or with bacterial ipopolysac- 
charide (LPS, E. coli 026:B6; Difco, Detroit, MI, USA). 
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2.2. Electrophoretic mobility shift assay 
Nuclear extracts were prepared as previously described [14,15]. Nu- 
clear protein-DNA-binding reactions were carried out in a volume of 
20 ~1 containing 5 pg nuclear extract protein, 10 mM Tris-HCl (pH 
7.5) 40 mM KCl, 1 mM EDTA, 1 mM dithiothreitol, 10% glycerol, 
2 fig of Poly(dI-dC) as a non-specific competitor and 10 fmol of 
5’-labelled double-stranded 22-mer oligonucleotide containing the 
NF-KB DNA-binding site (Promega, Madison, WI). The binding reac- 
tion was performed at room temperature for 30 min. Samples were 
analyzed by electrophoresis on 4% non-denaturing low-ionic strength 
polyacrylamide gels in 0.25 x TBE (22 mM Tris-borate, 22 mM boric 
acid, 0.5 mM EDTA). Gels were dried, visualized by autoradiography 
and analyzed by laser densitometry. 
2.3. Transfections and assay of CAT activity 
prcB/TKS-CAT and pcB/TK-lo-CAT were a generous gift of Dr. 
C.V. Jongeneel, Ludwig Institute, Epalinges, Switzerland [16]. Plas- 
mid DNA was introduced into HL-60 and THP-1 cells by electropora- 
tion (960 ,uF, 300 V) as previously described [17]. Immediately after 
transfection, the cells were stimulated. 16 h after stimulation, the cells 
were harvested for CAT assay. The cells were washed twice in PBS and 
resuspended in 0.25 M Tris-HCl, pH 7.8. Cell extracts were prepared 
by four cycles of freezing and thawing. The CAT reaction was per- 
formed and the samples were developed on a silica gel 60 thin-layer 
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chromatography (TLC) plate (Merck, Darmstadt, Germany), visual- 
ized by autoradiography and analyzed by laser densitometry. 
3. RESULTS 
3.1. Activation of NF-KB DNA-binding activity by 
Bt,cAMP 
To determine whether the membrane-permeable 
structural CAMP analog, Bt,cAMP, has an effect of 
NF-nB DNA-binding activity in human myeloid cells, 
nuclear proteins were extracted from untreated cells and 
cells treated with 1 mM Bt,cAMP and DNA-binding 
activity was studied by EMSA (Fig. 1). In promyelo- 
cytic HL-60 cells NF-KB DNA-binding activity in- 
creased time-dependently (Fig. 1A). The increased 
NF-KB DNA-binding activity becomes detectable in 
nuclear extracts of HL-60 cells after 3 h exposure to 
1 mM Bt,cAMP. An increase of approximately 3-fold 
was seen within 6 h of stimulation. In contrast, in the 
more mature monocytic THP-1 cells and human mon- 
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Fig. 1. Time-course for the induction of NF-xB binding activity in myeloid cells. Nuclear extracts were prepared from THP-1 cells (A), HL-60 
cells (A) or human monocytes (B) treated with culture medium alone (referred to as control), BYAMP (1 mM) or LPS (10 @ml) for indicated 
periods. The specificity of binding in THP-1 and HL-60 cells (C) and in human monocytes (D) was determined by competition with 200-fold molar 
excess of unlabelled double-stranded oligonucleotide. 
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Fig. 2. Activation of the NF-rcB enhancer. THP-1 (A) and HL-60 cells (B) were transfected with prcBfTK5 plasmid by electroporation. After 
transfection cells were cultured with or without Bt,cAMP (0.1 mM/l mM), BrcAMP (0.1 mMl1 mM), forskolin (Forsk.) (10 PM) or IBMX (0.5 
mM) for 16 h. CAT activity was assayed by thin-layer chromatography. Representative data of three independent experiments are shown. The 
unreacted substrate is labeled as C for chloramphenicol and the products are labeled as AC for acetylated chloramphenicols. 
ocytes 1 mM B&AMP induced only a slight increase 
in NF-FOB DNA-binding activity (Fig. 1A and B). Our 
studies are in accordance with previous studies showing 
that the basal activity level of NF-rcB is high in mature 
monocytic cells and in adherent human monocytes 
[ 18,191. We also found some basal activity in HL-60 
cells but it was lower compared to the more mature 
cells. The appearance of the increased NF-KB DNA- 
binding activity in the nuclei of human monocytes after 
Bt,cAMP treatment was slower compared to LPS-in- 
duced NF-rcB activity, which was detectable already 
after 1 h treatment (Fig. 1B). The specificity of 
Bt,cAMP-induced NF-KB DNA-binding activity was 
confirmed by competion of the DNA binding with a 200 
molar excess of unlabelled NF-KB oligonucleotide 
(Fig. 1C and D). 
3.2. Effect of Bt,cAMP on transcription mediated by 
NF-KB 
To investigate the role of elevated intracellular CAMP 
levels on transcriptional responses mediated by NF-FOB, 
we used CAT reporter constructs, p~cB/TK10 and p~cB/ 
TK5 contains two and six copies of NF-FcB binding sites 
of mouse TNF-a FCB enhancer, respectively, inserted in 
the pBLCAT2 expression vector [16]. The pnB/TKS 
construct was transfected into HL-60 and THP-1 cells 
by electroporation. Immediately after transfection the 
cells were treated with agents increasing the intracellu- 
lar CAMP levels (Fig. 2). In HL-60 cells a 4-fold increase 
in NF+B enhancer activity was seen after 1 mM 
Bt,cAMP treatment (Fig. 2A), whereas in THP-1 cells 
the increase was 2-fold (Fig. 2B). A similar, although 
weaker, effect was also seen with another CAMP analog, 
BrcAMP, or when the endogenous CAMP levels was 
increased with 10 PM forskolin, which directly stimu- 
lates adenylate/cyclase. Moreover, the forskolin-in- 
duced NF-KB enhancer activity was enhanced by 0.5 
mM IBMX, which indirectly elevates CAMP levels by 
inhibiting the CAMP-directed phosphodiesterase. In ad- 
dition, in HL-60 cells IBMX alone was able to induce 
some NF-lcB enhancer activity. These results are in ac- 
cordance with the EMSA data showing that in imma- 
ture myeloid cells NF-FOB activity is more inducible than 
in more mature cells. The number of NF-FOB binding 
sites did not have any effect on the NF-KB enhancer 
activity, since the same CAMP effect was seen with the 
reporter construct, pxB/TKlO, which contains two 
NF-FOB binding sites (data not shown). 
4. DISCUSSION 
In the present study we have shown that the increased 
intracellular CAMP levels stimulate NF-FOB DNA-bind- 
ing activity in human myeloid cells. In addition, tran- 
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sient transfection indicated that the enhanced binding 
activity leads to functional activation of a promoter 
containing the NF-FOB recognition site. 
Possible mediators of the NF-lcB activation are pro- 
tein kinases, protein phosphatases and oxygen radicals 
[lo]. The activation of NF-FOB by CAMP appears to 
differ depending on the cell type studied. In pre-B-cells 
CAMP induced the synthesis of Ic immunoglobulin light- 
chain via activation of NF-lcB-like DNA-binding pro- 
tein [20]. In addition, in human NK-cells NF+cB can be 
activated by treating cytoplasmic extracts with either 
PKC or PKA [21]. In contrast, Bomsztyk et al. [22] have 
previously shown that transient elevation of intracellu- 
lar CAMP by Bt,cAMP and PGE, is not sufficient to 
activate NF-lcB in the murine pre-B-cell line. 
The findings presented in this study show that the 
inducibility of NF-KB DNA-binding activity by CAMP 
is dependent on the maturation stage of myeloid cells. 
In the human promyelocytic HL-60 cells the CAMP 
analogs and the agents elevating the intracellular CAMP 
levels induced a significant NF-lcB activity, but in more 
mature THP-1 cells and in human monocytes, NF-lcB 
activity was poorly induced. Previously Griffin et al. 
[18] have shown that NF-FIB DNA-binding activity is 
developmentally regulated in the monocyte lineage. In 
the immature cell lines NF-lcB was inducible by phorbol 
esters, which causes the differentiation into mature 
monocytes and macrophages, whereas in the mature 
monocytic cell lines and in human monocytes NF-rcB 
was constitutively expressed. 
The different kinetics of DNA-binding observed after 
LPS and Bt,cAMP treatments in human monocytes in- 
dicated that, despite the ubiquitous nature of NF-KB, 
its activity is differentally regulated depending on the 
activation pathway. A crucial step in the activation of 
NF-KB is the inactivation of llcB, possibly by phospho- 
rylation. Recently Mufson et al. [ 193 have demonstrated 
that a basal PKC activity is needed for a constitutive 
NF-nB activity. Phorbol ester treatment leads to the 
down-regulation of PKC and to the disappearance of 
constitutive NF-lcB activity in immature and mature 
myeloid cells. The findings presented in this study sug- 
gest that the CAMP-dependent activation of NF-KB dif- 
fers from that induced by PKC, since the prolonged 
elevation of intracellular CAMP caused an increase in 
NF-KB activity, even in mature monocytes. 
IKB has been shown to be a substrate of PKC, 
whereas PKA does not phosphorylate 1x;B [23]. The 
members of the NF-lcB family have a potential phos- 
phorylation site (Arg-Arg-X-Ser) in a region containing 
a DNA-binding and a dimerization domain [24]. Rel 
protein is partly induced to migrate to the nucleus by 
phosphorylation at the conserved PKA site [25]. Ac- 
cording to our studies and those of others it can be 
proposed that PKA mediates the activation of NF-lcB 
by phosphorylating the components of NF-FOB. 
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